Behrens, F., Tak, P. P., Østergaard, M., Stoilov, R., Wiland, P., Huizinga, T. W., Berenfus, V. Y., Vladeva, S., Rech, J., Rubbert-Roth, A., Korkosz, M., Rekalov, D., Zupanets, I. A., Ejbjerg, B. J., Geiseler, J., Fresenius, J., Korolkiewicz, R. P., Schottelius, A. J., & Burkhardt, H. (2015). mOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the rheumatic diseases, 74(6), 1058–1064. http://access.bl.uk/ark:/81055/vdc_100135144960.0x000050